Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Oncorus
3112
Oncorus
Health Care
Medical
Technology
Biotechnology
Therapeutics
Oncorus is an early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer.
Suggest edits
Founded
2015
Raised
$84.5M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Capricor Therapeutics
PEP-Therapy
Fulgent Diagnostics
Centauri Therapeutics Limited
Therachon AG
Gadeta
Nuritas
Codiak Biosciences
Beijing Allcure Medical Technology
Arsia Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$79,500,000
Venture capital (Series B) - 2019
Perceptive Advisors
Cowen Healthcare Investments
£4,000,000
Venture capital (Series A) - 2016
Astellas Venture Management
Team Size
2
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$79,500,000
Venture capital (Series B)
PE HUB
Oncorus scores $79.5 mln Series B
£4,000,000
Venture capital (Series A)
biospace
,
FinSMEs
Oncorus Announces Additional Series A Financing Support From Astellas Venture Management LLC
Funding
Health
